Acetaminophen inhibits liver trytophan-2,3-dioxygenase activity with a concomitant rise in brain serotonin levels and a reduction in urinary 5-hydroxyindole acetic acid

Life Sci. 2000 Jun 8;67(3):235-40. doi: 10.1016/s0024-3205(00)00629-9.

Abstract

The effect of the analgesic agent, acetaminophen was determined on rat forebrain serotonin levels as well as hepatic tryptophan-2,3-dioxygenase (TDO) activity and urinary 5-hydroxyindole acetic acid (5-HIAA). The results show that acetaminophen administration (100mg/kg) over three hours does not affect the holoenzyme of tryptophan-2,3-dioxygenase but significantly inhibits the apoenzyme. This inhibition is accompanied by a concomitant rise in forebrain serotonin levels. This phenomenon is also accompanied by a reduction in urinary 5-HIAA levels. These results suggest that acetaminophen use is accompanied by changes in brain serotonin levels due to inhibition of hepatic tryptophan-2,3-dioxygenase activity. This in turn could explain the possible abuse potential of acetaminophen and its effects on mood at high doses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetaminophen / pharmacology*
  • Analgesics, Non-Narcotic / pharmacology*
  • Animals
  • Apoenzymes / antagonists & inhibitors
  • Enzyme Inhibitors / pharmacology
  • Hydroxyindoleacetic Acid / urine*
  • Liver / drug effects*
  • Liver / enzymology
  • Male
  • Prosencephalon / drug effects*
  • Prosencephalon / metabolism
  • Rats
  • Rats, Wistar
  • Serotonin / metabolism*
  • Tryptophan Oxygenase / antagonists & inhibitors*

Substances

  • Analgesics, Non-Narcotic
  • Apoenzymes
  • Enzyme Inhibitors
  • Serotonin
  • Acetaminophen
  • Hydroxyindoleacetic Acid
  • Tryptophan Oxygenase